FTC Increases Enforcement of Deceptive Advertising Claims to Sell Weight-Loss Programs
On December 3, 2025, the Federal Trade Commission announced that it has given final approval to an order against a telemedicine company and its principals, requiring them to stop the alleged deceptive advertising of weight-loss programs and to stop the alleged use of deceptive and unfair billing and cancellation practices.
In its July 2025 complaint, the FTC alleged that the company and certain individuals associated therewith “exploited skyrocketing interest in prescription glucagon-like peptide 1 agonist (GLP-1) weight-loss drugs like and Ozempic.” FTC lawyers also alleged they sold weight-loss programs with undisclosed costs and membership commitments, made unsubstantiated claims about the weight loss achieved by their clients, used fake testimonials, and unfairly distorted consumer reviews.
According to the FTC, the firm and its principals also allegedly failed to process cancellation and refund requests in a timely manner and failed to obtain express informed consent before charging consumers or making recurring debits, according to the complaint.
The final order requires the foregoing parties to pay $150,000, which is expected to be used to provide refunds to consumers.
The final order also:
- prohibits them from misrepresenting the cost of telehealth services;
- requires competent and reliable evidence to support claims about the average or typical results users will achieve;
- prohibits misrepresentations that reviews are truthful or from real consumers, and requires disclosure of any unexpected material connection with endorsers or reviewers;
- prohibits manipulation of reviews;
- requires them to obtain informed consent before billing consumers and authorization to use any electronic fund transfer; and
- requires them to clearly disclose important terms relating to refunds or cancellations before consumers are asked to pay, provide a simple way for consumers to request cancellations or refunds, and to promptly honor any cancellation or refund requests that comply with policies that were in effect at the time of purchase.
Contact an experienced FTC CID attorney if your company is involved in the marketing of weight-loss programs, including those that utilize free-trial programs and testimonials as part of an overall marketing strategy.
Richard B. Newman is a leading FTC compliance lawyer at Hinch Newman LLP.
Informational purposes only. Not legal advice. This article is not intended and should not be construed as legal advice. May be considered attorney advertising.
Topics
Archives
About This Blog and Hinch Newman’s Advertising + Marketing Practice
Hinch Newman LLP’s advertising and marketing practice includes two decades successfully resolving some of the highest-profile Federal Trade Commission (FTC) and state attorneys general digital advertising and telemarketing investigations and enforcement actions. The firm possesses superior knowledge and deep legal advocacy experience in the areas of advertising, marketing, lead generation, promotions, e-commerce, privacy and intellectual property law. It has also been selected to author the Consumer Protection Section of the prestigious American Lawyer Media International Federal Trade Commission: Law, Practice and Procedure Treatise, a comprehensive resource for developments of concern to advertisers, marketers and legal professionals that practice before the Commission. Through these advertising and marketing law updates, Hinch Newman LLP provides commentary, news and analysis on issues and trends concerning developments of interest to digital marketers, including FTC and state attorneys general advertising compliance, civil investigative demands (CIDs), and administrative/ judicial process.